Results 221 to 230 of about 215,881 (371)

The plastic scintillator detector for DAMPE [PDF]

, 2017
Yu-hong Yu, Zhiyu Sun, H. Su, Yaqing Yang, Jie Liu, J. Kong, G. Xiao, Xinwen Ma, Yonghui Zhou, Hongyun Zhao, D. Mo, Yongjie Zhang, Peng Yang, Junling Chen, Hai-Bo Yang, F. Fang, Shengxia Zhang, H. Yao, J. Duan, X. Niu, Zheng-guo Hu, Zhaomin Wang, Xiaohui Wang, Jingzhe Zhang, Wenqiang Liu   +24 more
semanticscholar   +1 more source

Divergence in μ and δ opioid receptor pharmacology in neurons and antinociceptive efficacy in neuropathic pain: Insights from MP135 and CYM51010

British Journal of Pharmacology, EarlyView.
Background and purpose Opioids targeting the μ opioid receptor remain largely ineffective in neuropathic pain conditions, emphasizing the need for novel therapeutic strategies. MP135 was reported to reduce thermal nociception in naive animals by activating μ‐δ opioid receptor heteromers.
Perrine Inquimbert, Chantal Fitterer, Sylvain Hugel, Mila Jesic, Yannick Goumon, Virgine Andry, Severine Schneider, Francois Daubeuf, Abdelfattah Faouzi, Stephane Doridot, Susruta Majumdar, Frederic Bihel, Martine Schmitt, Dominique Massotte   +13 more
wiley   +1 more source

Single-shot X-ray and near-infrared (NIR) dual-mode fusion imaging based on bifunctional NIR scintillators. [PDF]

Light Sci Appl
Ran P, Yang L, Hui J, Su Y, Chen Z, Zhu H, Kuang C, Liu X, Michael Yang Y.   +8 more
europepmc   +1 more source

Scintillation of Stars and the Atmosphere [PDF]

, 1952

openalex   +1 more source

Vesicular glutamate transporter VGLUT2 expression emerges in substantia nigra dopamine neurons in mouse models of parkinsonism in the absence of neurodegeneration

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Subsets of midbrain dopamine (DA) neurons express the vesicular glutamate transporter VGLUT2 and can release the excitatory neurotransmitter glutamate. VGLUT2+ DA neurons of the substantia nigra pars compacta (SNc) were shown to be more resistant to neurodegeneration in animal models of Parkinson's disease (PD ...
Sivakumar Srinivasan, Christian Pifl, Thomas Steinkellner   +2 more
wiley   +1 more source

In Situ Dose Measurements in Brachytherapy Using Scintillation Detectors Based on the Al₂O₃:C, Al₂O₃:C,Mg, and GAGG:Ce Crystals. [PDF]

Materials (Basel)
Witkiewicz-Lukaszek S, Winiecki J, Sobiech B, Akselrod M, Zorenko Y.   +4 more
europepmc   +1 more source

A PK/PD study on antihyperalgesia by an α2/3‐GABAA receptor PAM in mice: Lack of tolerance liability and potential involvement of γ1‐GABAA receptors

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose GABAA receptors (GABAARs) are heteropentameric ion channels that control almost all CNS functions, including spinal nociception. Most GABAARs contain a γ2 subunit but differ in their α and β subunit composition. TPA023B is an α2/α3 subtype selective, non‐sedative, positive allosteric modulator (PAM) with antihyperalgesic
Elena Neumann, Mariana O. Popa, Karen T. Elvers, Misa Oyama, Daniel Ulrich, Marcus Hanley, Gui Jie Feng, Thomas Hathaway, William T. Ralvenius, Thomas Grampp, Dietmar Benke, John R. Atack, Hanns Ulrich Zeilhofer   +12 more
wiley   +1 more source

High magnification optical imaging systems for the characterization of soft X-ray focii. [PDF]

J Synchrotron Radiat
Al Haddad A, Sarracini A, Schnorr K, Knopp G, Krempasky J, Arrell C, Augustin S, Bassement L, Brupbacher K, Vila-Comamala J, David C, Flechsig U, Follath R, Guo Z, Herzog M, Knurr J, Lombosi C, Manetti E, Mandal S, Morillo-Candas AS, Qi P, Sorokin BV, Stubbs S, Sun Z, Tiefenbacher SC, Vonka J, Wagner UH, Xie X, Yang N, Zhang H, Bostedt C.   +30 more
europepmc   +1 more source

Interstellar scintillation of sources B0821+394 and B1812+412 according to observations on the LPA LPI radio telescope

S. А. Tyul’bashev, И. В. Чашей, I. A. Grishanova, G. E. Tyul'basheva, И. А. Субаев   +4 more
openalex   +2 more sources

Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity

British Journal of Pharmacology, EarlyView.
Background and Purpose Dopamine receptor agonists, particularly targeting the dopamine D2L receptor (D2LR), have been used to treat Parkinson's disease (PD). However, valvular heart disease and somnolence, mainly caused by activating the serotonin 5‐HT2B receptor (5‐HT2BR) and dopamine D3 receptor (D3R), respectively, currently challenge their clinical
Takayuki Suzuki, Fumiki Oana, Masaki Oota, Yuma Handa, Osamu Kaminuma   +4 more
wiley   +1 more source